TSE:8354
TSE:8354Banks

Fukuoka Financial Group (TSE:8354) Valuation in Focus After Upgraded Guidance and Higher Dividend

Fukuoka Financial Group (TSE:8354) just released updated guidance, projecting higher consolidated net income for the next fiscal year. Alongside this, the company raised its second quarter dividend to JPY 85 per share, an increase from JPY 65 last year. See our latest analysis for Fukuoka Financial Group. News of higher net income guidance and the boosted dividend has clearly sparked renewed optimism around Fukuoka Financial Group. The 1-month share price return has reached 7.1%, with...
TSE:3769
TSE:3769Diversified Financial

How Investors May Respond To GMO Payment Gateway (TSE:3769) Dividend Hike and Upgraded Earnings Guidance

GMO Payment Gateway recently announced an increase in its annual dividend to ¥144.00 per share for the fiscal year ended September 2025, provided guidance for a further increase to ¥170.00 per share in the next fiscal year, and released updated earnings expectations for the next six and twelve-month periods. This combination of higher shareholder returns and detailed forward guidance offers insight into management’s capital allocation priorities and operational outlook. We'll examine how the...
TSE:2181
TSE:2181Professional Services

A Look at Persol Holdings (TSE:2181) Valuation Following Raised Dividend Guidance

Persol HoldingsLtd (TSE:2181) just raised its interim dividend guidance for the fiscal year ending March 2026, planning to pay JPY 5.50 per share instead of last year’s JPY 4.50. The scheduled payment date is December 10, 2025. See our latest analysis for Persol HoldingsLtd. Persol HoldingsLtd’s updated dividend outlook has clearly boosted sentiment, with a 10.2% share price return over the past month and a robust 22.4% gain year-to-date. While momentum is building in the short term, the...
TSE:4568
TSE:4568Pharmaceuticals

Could Daiichi Sankyo (TSE:4568) and Partner’s Push Into Protein Targets Signal a New R&D Strategy?

General Proximity announced a collaboration with Daiichi Sankyo’s Boston Research Institute to apply its OmniTAC discovery platform to identify new targets in cancer treatment, while also advancing programs in other disease areas. This partnership highlights Daiichi Sankyo’s continued investment in next-generation oncology research and its effort to address protein targets previously considered undruggable. We’ll examine how this expansion into novel protein targeting could reshape Daiichi...
TSE:4063
TSE:4063Chemicals

How a GaN Substrate Breakthrough Could Shape Shin-Etsu Chemical’s (TSE:4063) Role in Advanced Electronics

IMEC announced that Shin-Etsu Chemical's 300-mm QST substrate, developed in partnership with QROMIS, enabled a record-breaking voltage resistance in GaN power device evaluations, surpassing 800V and addressing key scalability challenges. This advance could accelerate the mass adoption of large-diameter GaN devices in fast-growing areas like AI data centers, electric vehicles, and industrial power systems. We'll examine how Shin-Etsu Chemical's breakthrough in large-diameter GaN substrate...